Filing Details
- Accession Number:
- 0001209191-20-027075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-05 16:12:37
- Reporting Period:
- 2020-05-01
- Accepted Time:
- 2020-05-05 16:12:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1639225 | Livongo Health Inc. | LVGO | Services-Computer Programming, Data Processing, Etc. (7370) | 263542036 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1783060 | Jennifer Schneider | C/O Livongo Health, Inc. 150 West Evelyn Avenue, Suite 150 Mountain View CA 94041 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-01 | 6,175 | $0.80 | 167,862 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-01 | 6,700 | $39.01 | 161,162 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-05-04 | 6,700 | $0.80 | 167,862 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-04 | 6,700 | $38.04 | 161,162 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-05-01 | 6,175 | $0.00 | 6,175 | $0.80 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-05-04 | 6,700 | $0.00 | 6,700 | $0.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 624,783 | 2025-09-02 | No | 4 | M | Direct | |
| 618,083 | 2025-09-02 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.58 to $39.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.83 to $38.49, inclusive.
- One-fourth of the shares subject to the option vested on September 1, 2016 and 1/48 of the shares vest monthly thereafter.
Billionaire Hedge Funds
